Skip to main content

Published locations for FDA expands ibrutinib approval to include chronic lymphocytic leukemia

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands ibrutinib approval to include chronic lymphocytic leukemia

User login

  • Reset your password
  • /content/fda-expands-ibrutinib-approval-include-chronic-lymphocytic-leukemia
  • /oncologypractice/article/80355/leukemia-myelodysplasia-transplantation/fda-expands-ibrutinib
  • /hematology-oncology/article/80355/leukemia-myelodysplasia-transplantation/fda-expands-ibrutinib